Edition:
United States

Profile: Sanofi SA (SNY.N)

SNY.N on New York Stock Exchange

50.34USD
22 Sep 2017
Change (% chg)

$0.39 (+0.78%)
Prev Close
$49.95
Open
$50.51
Day's High
$50.64
Day's Low
$50.17
Volume
106,490
Avg. Vol
158,013
52-wk High
$50.64
52-wk Low
$36.82

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company's segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme.

Company Address

Sanofi SA

54 rue la Boetie
PARIS     75008
P: +331.53774000
F: +331.53774463

Company Web Links